Company News
- HealioScan has rapidly evolved from a conceptual vision into a high-growth health-tech organization delivering measurable progress.
- 2023-2024: Core foundations established, research frameworks built, initial prototypes developed, and advisory leadership expanded.
- 2025: Operational scale-up underway with the introduction of PAMLEE™ system previews.
- 2027: Targeted launch of the fully deployed platform, advancing scalable, AI-powered cancer care with global impact.
In just a few short years, HealioScan has transformed from a bold idea into a fast-growing health-tech startup with tangible achievements.
Key milestones include:
- 2023: Foundations established, research framework built.
- 2024: Initial prototypes and advisory board expansion.
- 2025: Scaling operations and introducing PAMLEE previews.
- 2027: Target launch of the fully deployed system.
These milestones represent more than just dates—they reflect progress in saving lives through technology. With each phase, we come closer to delivering scalable, AI-powered solutions that will redefine cancer care globally.
